166
Participants
Start Date
May 31, 2009
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Saxagliptin plus metformin IR
Tablets, Oral, 2.5 mg, Twice daily, 12 weeks
Placebo plus metformin IR
Tablets, Oral, Placebo, Twice daily, 12 weeks
Local Institution, Budapest
Local Institution, Eger
Local Institution, Szigetvár
Local Institution, Balatonfüred
Local Institution, Zalaegerszeg
Integrated Medical Group Pc/Fleetwood Clinical Research, Fleetwood
Tidewater Integrated Medical Research, Virginia Beach
Southeastern Research Associates, Inc, Taylors
Middle Georgia Drug Study Center, Llc, Perry
Family Care Associates Of Nw Florida, Chipley
Central Florida Clinical Trials, Inc., Altamonte Springs
Clinical Therapeutics Corporation, Coral Gables
Nextphase Clinical Trials, Inc., Miami
Local Institution, Wüstensachsen
Local Institution, Tann
Holston Medical Group, Kingsport
Local Institution, Magdeberg
Jackson Clinic, Rolling Fork
Newark Physician Associates, Newark
Community Health Care Of Manchester, Akron
Midwest Regional Research, Inc., Bellbrook
Wells Institute For Health Awareness, Kettering
Local Institution, Saarbrücken
Local Institution, Saarlouis
Local Institution, Ludwigshafen
Louisiana Heart Center Research, Slidell
Integris Family Care Yukon, Yukon
Integris Family Care South, Oklahoma City
Village Family Practice, Houston
Southwest Clinical Research Centers, Llc, Pearland
Jolene K. Berg, Md., Dgd Research, Inc., San Antonio
Torrance Clinical Research, Lomita
Ritchken & First M.D.'S, San Diego
Southland Clinical Research Center, Inc., Fountain Valley
John Muir Physician Network Clinical Research Center, Concord
Williamette Valley Clinical Studies, Eugene
Local Institution, Pirna
Local Institution, Ponce
Local Institution, San Juan
Local Institution, San Juan
Local Institution, San Juan
Lead Sponsor
AstraZeneca
INDUSTRY